Synovus Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-419
| Closed | -$313K | – | 856 |
|
|
2021
Q3 | $313K | Sell |
419
-382
| -48% | -$285K | ﹤0.01% | 714 |
|
|
2021
Q2 | $523K | Buy |
+801
| New | +$523K | 0.01% | 601 |
|
|
2021
Q1 | – | Sell |
-727
| Closed | -$433K | – | 746 |
|
|
2020
Q4 | $433K | Sell |
727
-905
| -55% | -$539K | 0.01% | 575 |
|
|
2020
Q3 | $858K | Buy |
1,632
+53
| +3% | +$27.9K | 0.01% | 369 |
|
|
2020
Q2 | $712K | Sell |
1,579
-587
| -27% | -$265K | 0.01% | 390 |
|
|
2020
Q1 | $761K | Buy |
2,166
+339
| +19% | +$119K | 0.01% | 416 |
|
|
2019
Q4 | $673K | Sell |
1,827
-27
| -1% | -$9.95K | 0.01% | 403 |
|
|
2019
Q3 | $617K | Sell |
1,854
-1,471
| -44% | -$490K | 0.01% | 415 |
|
|
2019
Q2 | $1.04M | Buy |
3,325
+21
| +0.6% | +$6.59K | 0.02% | 328 |
|
|
2019
Q1 | $1.01M | Buy |
3,304
+511
| +18% | +$157K | 0.02% | 329 |
|
|
2018
Q4 | $651K | Sell |
2,793
-9
| -0.3% | -$2.1K | 0.01% | 380 |
|
|
2018
Q3 | $876K | Buy |
2,802
+41
| +1% | +$12.8K | 0.01% | 349 |
|
|
2018
Q2 | $797K | Buy |
2,761
+1,087
| +65% | +$314K | 0.01% | 354 |
|
|
2018
Q1 | $433K | Buy |
1,674
+704
| +73% | +$182K | 0.01% | 449 |
|
|
2017
Q4 | $233K | Buy |
970
+4
| +0.4% | +$961 | ﹤0.01% | 539 |
|
|
2017
Q3 | $222K | Buy |
966
+67
| +7% | +$15.4K | ﹤0.01% | 533 |
|
|
2017
Q2 | $209K | Buy |
899
+287
| +47% | +$66.7K | ﹤0.01% | 573 |
|
|
2017
Q1 | $123K | Buy |
612
+166
| +37% | +$33.4K | ﹤0.01% | 596 |
|
|
2016
Q4 | $78K | Buy |
+446
| New | +$78K | ﹤0.01% | 657 |
|